Current landscape of long COVID clinical trials.

Publication date: Mar 26, 2024

Long COVID was reported as a multi-systemic condition after the infection of SARS-CoV-2, and more than 65 million people are suffering from this disease. It has been noted that around 10% of severe SARS-CoV-2 infected individuals are suffering from the enduring effects of long COVID. The symptoms of long COVID have also been noted in several mild or asymptomatic SARS-CoV-2 infected individuals. While limited reports on clinical trials investigating new therapeutics for long COVID exist, there is an abundance of scattered information available regarding these trials. This review explores the extensive literature search, and complete clinical trial database search to map the current status of long COVID clinical trials worldwide. The study listed about 110 long COVID clinical trials. In addition to conducting extensive long COVID clinical trials, we have comprehensively presented an overview of the condition, its symptoms, notable manifestations, associated clinical trials, the unique challenges it poses, and our recommendations for addressing long COVID.

Concepts Keywords
Conducting Long COVID
Covid SARS-CoV-2
Extensive Treatment
Immunopharmacol

Semantics

Type Source Name
disease MESH long COVID
disease MESH infection
disease MESH sequelae
disease MESH COVID-19

Original Article

(Visited 1 times, 1 visits today)